SciELO - Scientific Electronic Library Online

vol.31 issue3Comparison of the Hyper-CVAD with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of MexicoMolecular techniques for detection and identification of pathogens in food: advantages and limitations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Peruana de Medicina Experimental y Salud Publica

Print version ISSN 1726-4634


VIRU-LOZA, Manuel A  and  PALACIOS-GUILLEN, Alaciel Melissa. Hyperuricemia and progression of chronic cardiorenal compromise. Rev. perú. med. exp. salud publica [online]. 2014, vol.31, n.3, pp.530-534. ISSN 1726-4634.

In order to determine whether hyperuricemia is associated with the progression of chronic cardiorenal compromise (CCC), a retrospective cohort study was performed which included 103 patients in whom CCC was defined as the simultaneous presence of chronic kidney disease (CKD) and chronic heart disease (CHD). CKD progression was defined as a 50% reduction of glomerular filtration rate estimated by the MDRD-4 equation. Hyperuricemia was defined as basal levels of uric acid ≥ 7 mg/dL. None of the studied variables showed association with the progression of CCC or CHD. Independent predictors of CKD progression were basal hyperuricemia (HR 4.41, 95% CI: 1.02-18.94) and SAP in followup (HR 1.05, 95% CI: 1.01-1.09). We conclude that hyperuricemia is an independent risk factor for the progression of CKD in patients with CCC.

Keywords : Uric acid; Hyperuricemia; Renal insufficiency, chronic; Cardio-renal syndrome; Arterial pressure; Follow-up studies; Disease progression.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License